Clinical Trial Update: Hybrid Florbetaben PET/MRI for Imaging of Cardiac Amyloidosis

View source ↗

Summary

This ClinicalTrials.gov entry reports a study using hybrid Florbetaben PET/MRI to image cardiac amyloidosis, currently recruiting at University Hospital, Essen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Amyloidosis

Drugs mentioned

• florbetaben (florbetaben)

Snippet

Sponsor: University Hospital, Essen | Conditions: Cardiac Amyloidosis | Status: RECRUITING